nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—PTGS1—breast cancer	0.201	0.631	CbGaD
Eszopiclone—CYP3A4—breast cancer	0.118	0.369	CbGaD
Eszopiclone—CYP2C9—Anastrozole—breast cancer	0.0327	0.0856	CbGbCtD
Eszopiclone—CYP2C8—Lapatinib—breast cancer	0.0313	0.0819	CbGbCtD
Eszopiclone—CYP3A4—Exemestane—breast cancer	0.0251	0.0657	CbGbCtD
Eszopiclone—CYP2C9—Idarubicin—breast cancer	0.0248	0.0649	CbGbCtD
Eszopiclone—CYP2C8—Raloxifene—breast cancer	0.0237	0.0621	CbGbCtD
Eszopiclone—CYP3A4—Letrozole—breast cancer	0.0214	0.0559	CbGbCtD
Eszopiclone—CYP3A4—Anastrozole—breast cancer	0.019	0.0498	CbGbCtD
Eszopiclone—CYP3A4—Toremifene—breast cancer	0.0174	0.0455	CbGbCtD
Eszopiclone—CYP3A4—Fulvestrant—breast cancer	0.0162	0.0423	CbGbCtD
Eszopiclone—CYP2C8—Tamoxifen—breast cancer	0.0157	0.041	CbGbCtD
Eszopiclone—CYP3A4—Thiotepa—breast cancer	0.0144	0.0377	CbGbCtD
Eszopiclone—CYP2C9—Capecitabine—breast cancer	0.0136	0.0356	CbGbCtD
Eszopiclone—CYP3A4—Ixabepilone—breast cancer	0.0132	0.0345	CbGbCtD
Eszopiclone—CYP3A4—Lapatinib—breast cancer	0.0127	0.0332	CbGbCtD
Eszopiclone—CYP2C8—Paclitaxel—breast cancer	0.0122	0.0319	CbGbCtD
Eszopiclone—CYP2C8—Fluorouracil—breast cancer	0.0116	0.0302	CbGbCtD
Eszopiclone—CYP2C9—Tamoxifen—breast cancer	0.0109	0.0286	CbGbCtD
Eszopiclone—CYP3A4—Raloxifene—breast cancer	0.00963	0.0252	CbGbCtD
Eszopiclone—CYP2C9—Paclitaxel—breast cancer	0.00852	0.0223	CbGbCtD
Eszopiclone—CYP2C9—Fluorouracil—breast cancer	0.00806	0.0211	CbGbCtD
Eszopiclone—CYP3A4—Vinorelbine—breast cancer	0.00705	0.0184	CbGbCtD
Eszopiclone—CYP3A4—Tamoxifen—breast cancer	0.00636	0.0166	CbGbCtD
Eszopiclone—CYP3A4—Mitoxantrone—breast cancer	0.0062	0.0162	CbGbCtD
Eszopiclone—CYP3A4—Paclitaxel—breast cancer	0.00495	0.0129	CbGbCtD
Eszopiclone—CYP3A4—Irinotecan—breast cancer	0.00489	0.0128	CbGbCtD
Eszopiclone—CYP3A4—Vinblastine—breast cancer	0.00434	0.0114	CbGbCtD
Eszopiclone—CYP3A4—Docetaxel—breast cancer	0.00358	0.00936	CbGbCtD
Eszopiclone—CYP3A4—Doxorubicin—breast cancer	0.00267	0.00698	CbGbCtD
Eszopiclone—Zopiclone—PTGS1—breast cancer	0.00156	0.631	CrCbGaD
Eszopiclone—Zopiclone—CYP3A4—breast cancer	0.000912	0.369	CrCbGaD
Eszopiclone—GABRG3—pituitary gland—breast cancer	0.000662	0.0545	CbGeAlD
Eszopiclone—TSPO—nipple—breast cancer	0.000598	0.0492	CbGeAlD
Eszopiclone—CYP2C8—mammary gland—breast cancer	0.000496	0.0408	CbGeAlD
Eszopiclone—TSPO—embryo—breast cancer	0.000494	0.0406	CbGeAlD
Eszopiclone—GABRA4—pituitary gland—breast cancer	0.000462	0.038	CbGeAlD
Eszopiclone—CYP2C9—mammary gland—breast cancer	0.000441	0.0363	CbGeAlD
Eszopiclone—TSPO—epithelium—breast cancer	0.000403	0.0331	CbGeAlD
Eszopiclone—GABRG2—pituitary gland—breast cancer	0.000386	0.0318	CbGeAlD
Eszopiclone—TSPO—skin of body—breast cancer	0.000383	0.0315	CbGeAlD
Eszopiclone—GABRA3—endocrine gland—breast cancer	0.000367	0.0302	CbGeAlD
Eszopiclone—TSPO—endometrium—breast cancer	0.000361	0.0297	CbGeAlD
Eszopiclone—GABRA2—adipose tissue—breast cancer	0.000352	0.0289	CbGeAlD
Eszopiclone—PTGS1—nipple—breast cancer	0.000333	0.0274	CbGeAlD
Eszopiclone—TSPO—uterus—breast cancer	0.000333	0.0274	CbGeAlD
Eszopiclone—TSPO—pituitary gland—breast cancer	0.000327	0.0269	CbGeAlD
Eszopiclone—TSPO—adipose tissue—breast cancer	0.000326	0.0268	CbGeAlD
Eszopiclone—GABRA2—adrenal gland—breast cancer	0.000315	0.026	CbGeAlD
Eszopiclone—TSPO—female reproductive system—breast cancer	0.000299	0.0246	CbGeAlD
Eszopiclone—TSPO—adrenal gland—breast cancer	0.000292	0.024	CbGeAlD
Eszopiclone—TSPO—bone marrow—breast cancer	0.000283	0.0232	CbGeAlD
Eszopiclone—TSPO—female gonad—breast cancer	0.000272	0.0224	CbGeAlD
Eszopiclone—TSPO—endocrine gland—breast cancer	0.000253	0.0208	CbGeAlD
Eszopiclone—CYP2C8—endometrium—breast cancer	0.000248	0.0204	CbGeAlD
Eszopiclone—CYP2C8—pituitary gland—breast cancer	0.000224	0.0185	CbGeAlD
Eszopiclone—PTGS1—epithelium—breast cancer	0.000224	0.0184	CbGeAlD
Eszopiclone—PTGS1—skin of body—breast cancer	0.000213	0.0175	CbGeAlD
Eszopiclone—CYP2C8—female reproductive system—breast cancer	0.000205	0.0169	CbGeAlD
Eszopiclone—PTGS1—endometrium—breast cancer	0.000201	0.0165	CbGeAlD
Eszopiclone—GABRA2—lymph node—breast cancer	0.000189	0.0156	CbGeAlD
Eszopiclone—PTGS1—uterus—breast cancer	0.000185	0.0152	CbGeAlD
Eszopiclone—CYP2C9—female reproductive system—breast cancer	0.000182	0.015	CbGeAlD
Eszopiclone—PTGS1—pituitary gland—breast cancer	0.000182	0.015	CbGeAlD
Eszopiclone—PTGS1—adipose tissue—breast cancer	0.000181	0.0149	CbGeAlD
Eszopiclone—TSPO—lymph node—breast cancer	0.000175	0.0144	CbGeAlD
Eszopiclone—CYP2C8—endocrine gland—breast cancer	0.000174	0.0143	CbGeAlD
Eszopiclone—PTGS1—female reproductive system—breast cancer	0.000167	0.0137	CbGeAlD
Eszopiclone—PTGS1—adrenal gland—breast cancer	0.000163	0.0134	CbGeAlD
Eszopiclone—CYP2C9—endocrine gland—breast cancer	0.000154	0.0127	CbGeAlD
Eszopiclone—PTGS1—female gonad—breast cancer	0.000152	0.0125	CbGeAlD
Eszopiclone—PTGS1—endocrine gland—breast cancer	0.000141	0.0116	CbGeAlD
Eszopiclone—CYP3A4—female reproductive system—breast cancer	0.000139	0.0114	CbGeAlD
Eszopiclone—CYP3A4—endocrine gland—breast cancer	0.000118	0.00969	CbGeAlD
Eszopiclone—PTGS1—lymph node—breast cancer	9.74e-05	0.00802	CbGeAlD
Eszopiclone—Hypoaesthesia—Epirubicin—breast cancer	4.06e-05	0.000177	CcSEcCtD
Eszopiclone—Pharyngitis—Epirubicin—breast cancer	4.05e-05	0.000177	CcSEcCtD
Eszopiclone—Sweating—Doxorubicin—breast cancer	4.03e-05	0.000176	CcSEcCtD
Eszopiclone—Urticaria—Paclitaxel—breast cancer	4.03e-05	0.000176	CcSEcCtD
Eszopiclone—Hyperhidrosis—Capecitabine—breast cancer	4.02e-05	0.000176	CcSEcCtD
Eszopiclone—Oedema peripheral—Epirubicin—breast cancer	4.02e-05	0.000176	CcSEcCtD
Eszopiclone—Haematuria—Doxorubicin—breast cancer	4.01e-05	0.000175	CcSEcCtD
Eszopiclone—Abdominal pain—Paclitaxel—breast cancer	4.01e-05	0.000175	CcSEcCtD
Eszopiclone—Body temperature increased—Paclitaxel—breast cancer	4.01e-05	0.000175	CcSEcCtD
Eszopiclone—Epistaxis—Doxorubicin—breast cancer	3.97e-05	0.000173	CcSEcCtD
Eszopiclone—Anorexia—Capecitabine—breast cancer	3.97e-05	0.000173	CcSEcCtD
Eszopiclone—Vomiting—Mitoxantrone—breast cancer	3.96e-05	0.000173	CcSEcCtD
Eszopiclone—Vomiting—Irinotecan—breast cancer	3.96e-05	0.000173	CcSEcCtD
Eszopiclone—Dizziness—Fluorouracil—breast cancer	3.94e-05	0.000172	CcSEcCtD
Eszopiclone—Rash—Irinotecan—breast cancer	3.92e-05	0.000171	CcSEcCtD
Eszopiclone—Rash—Mitoxantrone—breast cancer	3.92e-05	0.000171	CcSEcCtD
Eszopiclone—Dermatitis—Mitoxantrone—breast cancer	3.92e-05	0.000171	CcSEcCtD
Eszopiclone—Dermatitis—Irinotecan—breast cancer	3.92e-05	0.000171	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Docetaxel—breast cancer	3.92e-05	0.000171	CcSEcCtD
Eszopiclone—Chills—Methotrexate—breast cancer	3.91e-05	0.000171	CcSEcCtD
Eszopiclone—Headache—Mitoxantrone—breast cancer	3.9e-05	0.00017	CcSEcCtD
Eszopiclone—Headache—Irinotecan—breast cancer	3.9e-05	0.00017	CcSEcCtD
Eszopiclone—Insomnia—Docetaxel—breast cancer	3.89e-05	0.00017	CcSEcCtD
Eszopiclone—Paraesthesia—Docetaxel—breast cancer	3.86e-05	0.000169	CcSEcCtD
Eszopiclone—Erythema multiforme—Epirubicin—breast cancer	3.86e-05	0.000168	CcSEcCtD
Eszopiclone—Alopecia—Methotrexate—breast cancer	3.86e-05	0.000168	CcSEcCtD
Eszopiclone—Vomiting—Gemcitabine—breast cancer	3.85e-05	0.000168	CcSEcCtD
Eszopiclone—Dyspnoea—Docetaxel—breast cancer	3.83e-05	0.000167	CcSEcCtD
Eszopiclone—Somnolence—Docetaxel—breast cancer	3.82e-05	0.000167	CcSEcCtD
Eszopiclone—Rash—Gemcitabine—breast cancer	3.82e-05	0.000167	CcSEcCtD
Eszopiclone—Dermatitis—Gemcitabine—breast cancer	3.82e-05	0.000167	CcSEcCtD
Eszopiclone—Tinnitus—Epirubicin—breast cancer	3.81e-05	0.000166	CcSEcCtD
Eszopiclone—Headache—Gemcitabine—breast cancer	3.8e-05	0.000166	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Capecitabine—breast cancer	3.79e-05	0.000166	CcSEcCtD
Eszopiclone—Vomiting—Fluorouracil—breast cancer	3.79e-05	0.000165	CcSEcCtD
Eszopiclone—Rhinitis—Doxorubicin—breast cancer	3.79e-05	0.000165	CcSEcCtD
Eszopiclone—Dyspepsia—Docetaxel—breast cancer	3.79e-05	0.000165	CcSEcCtD
Eszopiclone—Hepatitis—Doxorubicin—breast cancer	3.78e-05	0.000165	CcSEcCtD
Eszopiclone—Insomnia—Capecitabine—breast cancer	3.77e-05	0.000164	CcSEcCtD
Eszopiclone—Hypoaesthesia—Doxorubicin—breast cancer	3.76e-05	0.000164	CcSEcCtD
Eszopiclone—Rash—Fluorouracil—breast cancer	3.76e-05	0.000164	CcSEcCtD
Eszopiclone—Dermatitis—Fluorouracil—breast cancer	3.75e-05	0.000164	CcSEcCtD
Eszopiclone—Pharyngitis—Doxorubicin—breast cancer	3.75e-05	0.000164	CcSEcCtD
Eszopiclone—Paraesthesia—Capecitabine—breast cancer	3.74e-05	0.000163	CcSEcCtD
Eszopiclone—Decreased appetite—Docetaxel—breast cancer	3.74e-05	0.000163	CcSEcCtD
Eszopiclone—Hypersensitivity—Paclitaxel—breast cancer	3.74e-05	0.000163	CcSEcCtD
Eszopiclone—Headache—Fluorouracil—breast cancer	3.73e-05	0.000163	CcSEcCtD
Eszopiclone—Oedema peripheral—Doxorubicin—breast cancer	3.72e-05	0.000162	CcSEcCtD
Eszopiclone—Dysgeusia—Methotrexate—breast cancer	3.72e-05	0.000162	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Docetaxel—breast cancer	3.71e-05	0.000162	CcSEcCtD
Eszopiclone—Dyspnoea—Capecitabine—breast cancer	3.71e-05	0.000162	CcSEcCtD
Eszopiclone—Fatigue—Docetaxel—breast cancer	3.71e-05	0.000162	CcSEcCtD
Eszopiclone—Nausea—Mitoxantrone—breast cancer	3.7e-05	0.000161	CcSEcCtD
Eszopiclone—Nausea—Irinotecan—breast cancer	3.7e-05	0.000161	CcSEcCtD
Eszopiclone—Pain—Docetaxel—breast cancer	3.68e-05	0.00016	CcSEcCtD
Eszopiclone—Constipation—Docetaxel—breast cancer	3.68e-05	0.00016	CcSEcCtD
Eszopiclone—Back pain—Methotrexate—breast cancer	3.67e-05	0.00016	CcSEcCtD
Eszopiclone—Dyspepsia—Capecitabine—breast cancer	3.66e-05	0.00016	CcSEcCtD
Eszopiclone—Chills—Epirubicin—breast cancer	3.66e-05	0.00016	CcSEcCtD
Eszopiclone—Asthenia—Paclitaxel—breast cancer	3.64e-05	0.000159	CcSEcCtD
Eszopiclone—Decreased appetite—Capecitabine—breast cancer	3.62e-05	0.000158	CcSEcCtD
Eszopiclone—Alopecia—Epirubicin—breast cancer	3.61e-05	0.000157	CcSEcCtD
Eszopiclone—Nausea—Gemcitabine—breast cancer	3.6e-05	0.000157	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Capecitabine—breast cancer	3.59e-05	0.000157	CcSEcCtD
Eszopiclone—Fatigue—Capecitabine—breast cancer	3.59e-05	0.000157	CcSEcCtD
Eszopiclone—Pruritus—Paclitaxel—breast cancer	3.59e-05	0.000157	CcSEcCtD
Eszopiclone—Vision blurred—Methotrexate—breast cancer	3.58e-05	0.000156	CcSEcCtD
Eszopiclone—Erythema multiforme—Doxorubicin—breast cancer	3.57e-05	0.000156	CcSEcCtD
Eszopiclone—Pain—Capecitabine—breast cancer	3.56e-05	0.000155	CcSEcCtD
Eszopiclone—Constipation—Capecitabine—breast cancer	3.56e-05	0.000155	CcSEcCtD
Eszopiclone—Feeling abnormal—Docetaxel—breast cancer	3.54e-05	0.000155	CcSEcCtD
Eszopiclone—Nausea—Fluorouracil—breast cancer	3.54e-05	0.000154	CcSEcCtD
Eszopiclone—Ill-defined disorder—Methotrexate—breast cancer	3.52e-05	0.000154	CcSEcCtD
Eszopiclone—Tinnitus—Doxorubicin—breast cancer	3.52e-05	0.000154	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Docetaxel—breast cancer	3.52e-05	0.000153	CcSEcCtD
Eszopiclone—Anaemia—Methotrexate—breast cancer	3.51e-05	0.000153	CcSEcCtD
Eszopiclone—Tension—Epirubicin—breast cancer	3.49e-05	0.000152	CcSEcCtD
Eszopiclone—Dysgeusia—Epirubicin—breast cancer	3.48e-05	0.000152	CcSEcCtD
Eszopiclone—Diarrhoea—Paclitaxel—breast cancer	3.47e-05	0.000152	CcSEcCtD
Eszopiclone—Nervousness—Epirubicin—breast cancer	3.45e-05	0.000151	CcSEcCtD
Eszopiclone—Back pain—Epirubicin—breast cancer	3.44e-05	0.00015	CcSEcCtD
Eszopiclone—Feeling abnormal—Capecitabine—breast cancer	3.43e-05	0.00015	CcSEcCtD
Eszopiclone—Malaise—Methotrexate—breast cancer	3.42e-05	0.000149	CcSEcCtD
Eszopiclone—Muscle spasms—Epirubicin—breast cancer	3.42e-05	0.000149	CcSEcCtD
Eszopiclone—Vertigo—Methotrexate—breast cancer	3.41e-05	0.000149	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Capecitabine—breast cancer	3.4e-05	0.000149	CcSEcCtD
Eszopiclone—Abdominal pain—Docetaxel—breast cancer	3.4e-05	0.000148	CcSEcCtD
Eszopiclone—Body temperature increased—Docetaxel—breast cancer	3.4e-05	0.000148	CcSEcCtD
Eszopiclone—Chills—Doxorubicin—breast cancer	3.39e-05	0.000148	CcSEcCtD
Eszopiclone—Dizziness—Paclitaxel—breast cancer	3.35e-05	0.000146	CcSEcCtD
Eszopiclone—Vision blurred—Epirubicin—breast cancer	3.35e-05	0.000146	CcSEcCtD
Eszopiclone—Alopecia—Doxorubicin—breast cancer	3.34e-05	0.000146	CcSEcCtD
Eszopiclone—Urticaria—Capecitabine—breast cancer	3.31e-05	0.000144	CcSEcCtD
Eszopiclone—Ill-defined disorder—Epirubicin—breast cancer	3.3e-05	0.000144	CcSEcCtD
Eszopiclone—Abdominal pain—Capecitabine—breast cancer	3.29e-05	0.000144	CcSEcCtD
Eszopiclone—Body temperature increased—Capecitabine—breast cancer	3.29e-05	0.000144	CcSEcCtD
Eszopiclone—Convulsion—Methotrexate—breast cancer	3.29e-05	0.000144	CcSEcCtD
Eszopiclone—Anaemia—Epirubicin—breast cancer	3.28e-05	0.000143	CcSEcCtD
Eszopiclone—Agitation—Epirubicin—breast cancer	3.27e-05	0.000143	CcSEcCtD
Eszopiclone—Myalgia—Methotrexate—breast cancer	3.23e-05	0.000141	CcSEcCtD
Eszopiclone—Chest pain—Methotrexate—breast cancer	3.23e-05	0.000141	CcSEcCtD
Eszopiclone—Tension—Doxorubicin—breast cancer	3.23e-05	0.000141	CcSEcCtD
Eszopiclone—Vomiting—Paclitaxel—breast cancer	3.23e-05	0.000141	CcSEcCtD
Eszopiclone—Dysgeusia—Doxorubicin—breast cancer	3.22e-05	0.000141	CcSEcCtD
Eszopiclone—Malaise—Epirubicin—breast cancer	3.2e-05	0.00014	CcSEcCtD
Eszopiclone—Rash—Paclitaxel—breast cancer	3.2e-05	0.00014	CcSEcCtD
Eszopiclone—Dermatitis—Paclitaxel—breast cancer	3.2e-05	0.000139	CcSEcCtD
Eszopiclone—Discomfort—Methotrexate—breast cancer	3.19e-05	0.000139	CcSEcCtD
Eszopiclone—Nervousness—Doxorubicin—breast cancer	3.19e-05	0.000139	CcSEcCtD
Eszopiclone—Vertigo—Epirubicin—breast cancer	3.19e-05	0.000139	CcSEcCtD
Eszopiclone—Back pain—Doxorubicin—breast cancer	3.18e-05	0.000139	CcSEcCtD
Eszopiclone—Headache—Paclitaxel—breast cancer	3.18e-05	0.000139	CcSEcCtD
Eszopiclone—Hypersensitivity—Docetaxel—breast cancer	3.17e-05	0.000138	CcSEcCtD
Eszopiclone—Muscle spasms—Doxorubicin—breast cancer	3.16e-05	0.000138	CcSEcCtD
Eszopiclone—Palpitations—Epirubicin—breast cancer	3.14e-05	0.000137	CcSEcCtD
Eszopiclone—Confusional state—Methotrexate—breast cancer	3.13e-05	0.000136	CcSEcCtD
Eszopiclone—Anaphylactic shock—Methotrexate—breast cancer	3.1e-05	0.000135	CcSEcCtD
Eszopiclone—Vision blurred—Doxorubicin—breast cancer	3.1e-05	0.000135	CcSEcCtD
Eszopiclone—Asthenia—Docetaxel—breast cancer	3.09e-05	0.000135	CcSEcCtD
Eszopiclone—Convulsion—Epirubicin—breast cancer	3.08e-05	0.000134	CcSEcCtD
Eszopiclone—Infection—Methotrexate—breast cancer	3.08e-05	0.000134	CcSEcCtD
Eszopiclone—Hypertension—Epirubicin—breast cancer	3.07e-05	0.000134	CcSEcCtD
Eszopiclone—Hypersensitivity—Capecitabine—breast cancer	3.07e-05	0.000134	CcSEcCtD
Eszopiclone—Ill-defined disorder—Doxorubicin—breast cancer	3.05e-05	0.000133	CcSEcCtD
Eszopiclone—Pruritus—Docetaxel—breast cancer	3.04e-05	0.000133	CcSEcCtD
Eszopiclone—Anaemia—Doxorubicin—breast cancer	3.04e-05	0.000133	CcSEcCtD
Eszopiclone—Myalgia—Epirubicin—breast cancer	3.03e-05	0.000132	CcSEcCtD
Eszopiclone—Chest pain—Epirubicin—breast cancer	3.03e-05	0.000132	CcSEcCtD
Eszopiclone—Agitation—Doxorubicin—breast cancer	3.02e-05	0.000132	CcSEcCtD
Eszopiclone—Anxiety—Epirubicin—breast cancer	3.02e-05	0.000132	CcSEcCtD
Eszopiclone—Nausea—Paclitaxel—breast cancer	3.01e-05	0.000132	CcSEcCtD
Eszopiclone—Hyperhidrosis—Methotrexate—breast cancer	3e-05	0.000131	CcSEcCtD
Eszopiclone—Discomfort—Epirubicin—breast cancer	2.99e-05	0.00013	CcSEcCtD
Eszopiclone—Asthenia—Capecitabine—breast cancer	2.99e-05	0.00013	CcSEcCtD
Eszopiclone—Malaise—Doxorubicin—breast cancer	2.97e-05	0.000129	CcSEcCtD
Eszopiclone—Dry mouth—Epirubicin—breast cancer	2.96e-05	0.000129	CcSEcCtD
Eszopiclone—Vertigo—Doxorubicin—breast cancer	2.95e-05	0.000129	CcSEcCtD
Eszopiclone—Anorexia—Methotrexate—breast cancer	2.95e-05	0.000129	CcSEcCtD
Eszopiclone—Pruritus—Capecitabine—breast cancer	2.95e-05	0.000129	CcSEcCtD
Eszopiclone—Diarrhoea—Docetaxel—breast cancer	2.94e-05	0.000128	CcSEcCtD
Eszopiclone—Confusional state—Epirubicin—breast cancer	2.92e-05	0.000128	CcSEcCtD
Eszopiclone—Palpitations—Doxorubicin—breast cancer	2.91e-05	0.000127	CcSEcCtD
Eszopiclone—Anaphylactic shock—Epirubicin—breast cancer	2.9e-05	0.000127	CcSEcCtD
Eszopiclone—Infection—Epirubicin—breast cancer	2.88e-05	0.000126	CcSEcCtD
Eszopiclone—Convulsion—Doxorubicin—breast cancer	2.85e-05	0.000124	CcSEcCtD
Eszopiclone—Diarrhoea—Capecitabine—breast cancer	2.85e-05	0.000124	CcSEcCtD
Eszopiclone—Dizziness—Docetaxel—breast cancer	2.84e-05	0.000124	CcSEcCtD
Eszopiclone—Hypertension—Doxorubicin—breast cancer	2.84e-05	0.000124	CcSEcCtD
Eszopiclone—Tachycardia—Epirubicin—breast cancer	2.83e-05	0.000124	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Methotrexate—breast cancer	2.82e-05	0.000123	CcSEcCtD
Eszopiclone—Hyperhidrosis—Epirubicin—breast cancer	2.8e-05	0.000122	CcSEcCtD
Eszopiclone—Insomnia—Methotrexate—breast cancer	2.8e-05	0.000122	CcSEcCtD
Eszopiclone—Myalgia—Doxorubicin—breast cancer	2.8e-05	0.000122	CcSEcCtD
Eszopiclone—Chest pain—Doxorubicin—breast cancer	2.8e-05	0.000122	CcSEcCtD
Eszopiclone—Anxiety—Doxorubicin—breast cancer	2.79e-05	0.000122	CcSEcCtD
Eszopiclone—Paraesthesia—Methotrexate—breast cancer	2.78e-05	0.000121	CcSEcCtD
Eszopiclone—Discomfort—Doxorubicin—breast cancer	2.77e-05	0.000121	CcSEcCtD
Eszopiclone—Anorexia—Epirubicin—breast cancer	2.76e-05	0.000121	CcSEcCtD
Eszopiclone—Dyspnoea—Methotrexate—breast cancer	2.76e-05	0.000121	CcSEcCtD
Eszopiclone—Somnolence—Methotrexate—breast cancer	2.76e-05	0.00012	CcSEcCtD
Eszopiclone—Dizziness—Capecitabine—breast cancer	2.75e-05	0.00012	CcSEcCtD
Eszopiclone—Dry mouth—Doxorubicin—breast cancer	2.74e-05	0.000119	CcSEcCtD
Eszopiclone—Vomiting—Docetaxel—breast cancer	2.73e-05	0.000119	CcSEcCtD
Eszopiclone—Dyspepsia—Methotrexate—breast cancer	2.73e-05	0.000119	CcSEcCtD
Eszopiclone—Rash—Docetaxel—breast cancer	2.71e-05	0.000118	CcSEcCtD
Eszopiclone—Dermatitis—Docetaxel—breast cancer	2.71e-05	0.000118	CcSEcCtD
Eszopiclone—Confusional state—Doxorubicin—breast cancer	2.71e-05	0.000118	CcSEcCtD
Eszopiclone—Decreased appetite—Methotrexate—breast cancer	2.69e-05	0.000118	CcSEcCtD
Eszopiclone—Headache—Docetaxel—breast cancer	2.69e-05	0.000118	CcSEcCtD
Eszopiclone—Anaphylactic shock—Doxorubicin—breast cancer	2.68e-05	0.000117	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Methotrexate—breast cancer	2.68e-05	0.000117	CcSEcCtD
Eszopiclone—Fatigue—Methotrexate—breast cancer	2.67e-05	0.000117	CcSEcCtD
Eszopiclone—Infection—Doxorubicin—breast cancer	2.67e-05	0.000116	CcSEcCtD
Eszopiclone—Pain—Methotrexate—breast cancer	2.65e-05	0.000116	CcSEcCtD
Eszopiclone—Vomiting—Capecitabine—breast cancer	2.65e-05	0.000116	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Epirubicin—breast cancer	2.64e-05	0.000115	CcSEcCtD
Eszopiclone—Rash—Capecitabine—breast cancer	2.63e-05	0.000115	CcSEcCtD
Eszopiclone—Insomnia—Epirubicin—breast cancer	2.62e-05	0.000114	CcSEcCtD
Eszopiclone—Dermatitis—Capecitabine—breast cancer	2.62e-05	0.000114	CcSEcCtD
Eszopiclone—Tachycardia—Doxorubicin—breast cancer	2.62e-05	0.000114	CcSEcCtD
Eszopiclone—Headache—Capecitabine—breast cancer	2.61e-05	0.000114	CcSEcCtD
Eszopiclone—Paraesthesia—Epirubicin—breast cancer	2.6e-05	0.000114	CcSEcCtD
Eszopiclone—Hyperhidrosis—Doxorubicin—breast cancer	2.59e-05	0.000113	CcSEcCtD
Eszopiclone—Dyspnoea—Epirubicin—breast cancer	2.59e-05	0.000113	CcSEcCtD
Eszopiclone—Somnolence—Epirubicin—breast cancer	2.58e-05	0.000113	CcSEcCtD
Eszopiclone—Anorexia—Doxorubicin—breast cancer	2.56e-05	0.000112	CcSEcCtD
Eszopiclone—Nausea—Docetaxel—breast cancer	2.55e-05	0.000111	CcSEcCtD
Eszopiclone—Feeling abnormal—Methotrexate—breast cancer	2.55e-05	0.000111	CcSEcCtD
Eszopiclone—Dyspepsia—Epirubicin—breast cancer	2.55e-05	0.000111	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Methotrexate—breast cancer	2.53e-05	0.000111	CcSEcCtD
Eszopiclone—Decreased appetite—Epirubicin—breast cancer	2.52e-05	0.00011	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Epirubicin—breast cancer	2.5e-05	0.000109	CcSEcCtD
Eszopiclone—Fatigue—Epirubicin—breast cancer	2.5e-05	0.000109	CcSEcCtD
Eszopiclone—Pain—Epirubicin—breast cancer	2.48e-05	0.000108	CcSEcCtD
Eszopiclone—Constipation—Epirubicin—breast cancer	2.48e-05	0.000108	CcSEcCtD
Eszopiclone—Nausea—Capecitabine—breast cancer	2.47e-05	0.000108	CcSEcCtD
Eszopiclone—Urticaria—Methotrexate—breast cancer	2.46e-05	0.000107	CcSEcCtD
Eszopiclone—Abdominal pain—Methotrexate—breast cancer	2.45e-05	0.000107	CcSEcCtD
Eszopiclone—Body temperature increased—Methotrexate—breast cancer	2.45e-05	0.000107	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.45e-05	0.000107	CcSEcCtD
Eszopiclone—Insomnia—Doxorubicin—breast cancer	2.43e-05	0.000106	CcSEcCtD
Eszopiclone—Paraesthesia—Doxorubicin—breast cancer	2.41e-05	0.000105	CcSEcCtD
Eszopiclone—Dyspnoea—Doxorubicin—breast cancer	2.39e-05	0.000104	CcSEcCtD
Eszopiclone—Feeling abnormal—Epirubicin—breast cancer	2.39e-05	0.000104	CcSEcCtD
Eszopiclone—Somnolence—Doxorubicin—breast cancer	2.39e-05	0.000104	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Epirubicin—breast cancer	2.37e-05	0.000104	CcSEcCtD
Eszopiclone—Dyspepsia—Doxorubicin—breast cancer	2.36e-05	0.000103	CcSEcCtD
Eszopiclone—Decreased appetite—Doxorubicin—breast cancer	2.33e-05	0.000102	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Doxorubicin—breast cancer	2.32e-05	0.000101	CcSEcCtD
Eszopiclone—Fatigue—Doxorubicin—breast cancer	2.31e-05	0.000101	CcSEcCtD
Eszopiclone—Urticaria—Epirubicin—breast cancer	2.3e-05	0.000101	CcSEcCtD
Eszopiclone—Pain—Doxorubicin—breast cancer	2.3e-05	0.0001	CcSEcCtD
Eszopiclone—Constipation—Doxorubicin—breast cancer	2.3e-05	0.0001	CcSEcCtD
Eszopiclone—Abdominal pain—Epirubicin—breast cancer	2.29e-05	0.0001	CcSEcCtD
Eszopiclone—Body temperature increased—Epirubicin—breast cancer	2.29e-05	0.0001	CcSEcCtD
Eszopiclone—Hypersensitivity—Methotrexate—breast cancer	2.28e-05	9.97e-05	CcSEcCtD
Eszopiclone—Asthenia—Methotrexate—breast cancer	2.22e-05	9.71e-05	CcSEcCtD
Eszopiclone—Feeling abnormal—Doxorubicin—breast cancer	2.21e-05	9.65e-05	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Doxorubicin—breast cancer	2.19e-05	9.58e-05	CcSEcCtD
Eszopiclone—Pruritus—Methotrexate—breast cancer	2.19e-05	9.57e-05	CcSEcCtD
Eszopiclone—Hypersensitivity—Epirubicin—breast cancer	2.14e-05	9.33e-05	CcSEcCtD
Eszopiclone—Urticaria—Doxorubicin—breast cancer	2.13e-05	9.31e-05	CcSEcCtD
Eszopiclone—Abdominal pain—Doxorubicin—breast cancer	2.12e-05	9.26e-05	CcSEcCtD
Eszopiclone—Body temperature increased—Doxorubicin—breast cancer	2.12e-05	9.26e-05	CcSEcCtD
Eszopiclone—Diarrhoea—Methotrexate—breast cancer	2.12e-05	9.26e-05	CcSEcCtD
Eszopiclone—Asthenia—Epirubicin—breast cancer	2.08e-05	9.08e-05	CcSEcCtD
Eszopiclone—Pruritus—Epirubicin—breast cancer	2.05e-05	8.96e-05	CcSEcCtD
Eszopiclone—Dizziness—Methotrexate—breast cancer	2.05e-05	8.95e-05	CcSEcCtD
Eszopiclone—Diarrhoea—Epirubicin—breast cancer	1.98e-05	8.66e-05	CcSEcCtD
Eszopiclone—Hypersensitivity—Doxorubicin—breast cancer	1.98e-05	8.63e-05	CcSEcCtD
Eszopiclone—Vomiting—Methotrexate—breast cancer	1.97e-05	8.6e-05	CcSEcCtD
Eszopiclone—Rash—Methotrexate—breast cancer	1.95e-05	8.53e-05	CcSEcCtD
Eszopiclone—Dermatitis—Methotrexate—breast cancer	1.95e-05	8.52e-05	CcSEcCtD
Eszopiclone—Headache—Methotrexate—breast cancer	1.94e-05	8.47e-05	CcSEcCtD
Eszopiclone—Asthenia—Doxorubicin—breast cancer	1.93e-05	8.4e-05	CcSEcCtD
Eszopiclone—Dizziness—Epirubicin—breast cancer	1.92e-05	8.37e-05	CcSEcCtD
Eszopiclone—Pruritus—Doxorubicin—breast cancer	1.9e-05	8.29e-05	CcSEcCtD
Eszopiclone—Vomiting—Epirubicin—breast cancer	1.84e-05	8.05e-05	CcSEcCtD
Eszopiclone—Nausea—Methotrexate—breast cancer	1.84e-05	8.03e-05	CcSEcCtD
Eszopiclone—Diarrhoea—Doxorubicin—breast cancer	1.84e-05	8.01e-05	CcSEcCtD
Eszopiclone—Rash—Epirubicin—breast cancer	1.83e-05	7.98e-05	CcSEcCtD
Eszopiclone—Dermatitis—Epirubicin—breast cancer	1.83e-05	7.97e-05	CcSEcCtD
Eszopiclone—Headache—Epirubicin—breast cancer	1.82e-05	7.93e-05	CcSEcCtD
Eszopiclone—Dizziness—Doxorubicin—breast cancer	1.77e-05	7.75e-05	CcSEcCtD
Eszopiclone—Nausea—Epirubicin—breast cancer	1.72e-05	7.52e-05	CcSEcCtD
Eszopiclone—Vomiting—Doxorubicin—breast cancer	1.71e-05	7.45e-05	CcSEcCtD
Eszopiclone—Rash—Doxorubicin—breast cancer	1.69e-05	7.39e-05	CcSEcCtD
Eszopiclone—Dermatitis—Doxorubicin—breast cancer	1.69e-05	7.38e-05	CcSEcCtD
Eszopiclone—Headache—Doxorubicin—breast cancer	1.68e-05	7.34e-05	CcSEcCtD
Eszopiclone—Nausea—Doxorubicin—breast cancer	1.59e-05	6.96e-05	CcSEcCtD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.67e-06	0.000139	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP3A4—breast cancer	7.64e-06	0.000139	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.6e-06	0.000138	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ABCC1—breast cancer	7.52e-06	0.000137	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTA3—breast cancer	7.52e-06	0.000137	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HMMR—breast cancer	7.52e-06	0.000137	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP1B1—breast cancer	7.51e-06	0.000137	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HSP90AA1—breast cancer	7.36e-06	0.000134	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PPARGC1B—breast cancer	7.28e-06	0.000132	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NCOA1—breast cancer	7.16e-06	0.00013	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—breast cancer	7.1e-06	0.000129	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	7.09e-06	0.000129	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	7.09e-06	0.000129	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP19A1—breast cancer	7.06e-06	0.000128	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—STK11—breast cancer	7.06e-06	0.000128	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SHMT1—breast cancer	7.04e-06	0.000128	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CDA—breast cancer	7.04e-06	0.000128	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MED12—breast cancer	6.89e-06	0.000125	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—DPYD—breast cancer	6.89e-06	0.000125	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTA4—breast cancer	6.87e-06	0.000125	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CA9—breast cancer	6.87e-06	0.000125	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	6.79e-06	0.000123	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ALDOA—breast cancer	6.78e-06	0.000123	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLCO1B1—breast cancer	6.77e-06	0.000123	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC2A5—breast cancer	6.77e-06	0.000123	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	6.72e-06	0.000122	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GPX2—breast cancer	6.7e-06	0.000122	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTA2—breast cancer	6.7e-06	0.000122	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.63e-06	0.000121	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GPX4—breast cancer	6.62e-06	0.00012	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SULT1A1—breast cancer	6.62e-06	0.00012	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NCOA3—breast cancer	6.58e-06	0.00012	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—COMT—breast cancer	6.56e-06	0.000119	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—APRT—breast cancer	6.54e-06	0.000119	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC2A2—breast cancer	6.53e-06	0.000119	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTP1—breast cancer	6.53e-06	0.000119	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	6.47e-06	0.000118	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTA1—breast cancer	6.46e-06	0.000118	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—IDH1—breast cancer	6.46e-06	0.000118	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HMOX1—breast cancer	6.44e-06	0.000117	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ITPR1—breast cancer	6.43e-06	0.000117	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ABCG2—breast cancer	6.4e-06	0.000116	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CPT1A—breast cancer	6.4e-06	0.000116	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MTR—breast cancer	6.4e-06	0.000116	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NAT2—breast cancer	6.39e-06	0.000116	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HPGDS—breast cancer	6.28e-06	0.000114	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HBA1—breast cancer	6.24e-06	0.000113	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ABCB1—breast cancer	6.18e-06	0.000112	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ESRRA—breast cancer	6.15e-06	0.000112	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ANGPTL4—breast cancer	6.15e-06	0.000112	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ACHE—breast cancer	6.09e-06	0.000111	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTT1—breast cancer	6.09e-06	0.000111	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—TYMS—breast cancer	6.07e-06	0.00011	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTM1—breast cancer	6e-06	0.000109	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PLA2G4A—breast cancer	6e-06	0.000109	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NCOR1—breast cancer	6e-06	0.000109	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HADHB—breast cancer	5.83e-06	0.000106	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GPI—breast cancer	5.83e-06	0.000106	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	5.78e-06	0.000105	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP17A1—breast cancer	5.76e-06	0.000105	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GPX1—breast cancer	5.75e-06	0.000105	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ENO1—breast cancer	5.71e-06	0.000104	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTGS1—breast cancer	5.71e-06	0.000104	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP1A1—breast cancer	5.69e-06	0.000103	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.68e-06	0.000103	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ERCC2—breast cancer	5.64e-06	0.000103	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.61e-06	0.000102	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—DPYD—breast cancer	5.6e-06	0.000102	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MED12—breast cancer	5.6e-06	0.000102	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP2D6—breast cancer	5.59e-06	0.000102	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALDH1A1—breast cancer	5.56e-06	0.000101	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALDH7A1—breast cancer	5.56e-06	0.000101	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ALDOA—breast cancer	5.52e-06	0.0001	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NCOA2—breast cancer	5.49e-06	9.99e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NCOA3—breast cancer	5.36e-06	9.74e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ADSL—breast cancer	5.33e-06	9.69e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—UMPS—breast cancer	5.33e-06	9.69e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NME1—breast cancer	5.33e-06	9.69e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—FHL2—breast cancer	5.33e-06	9.69e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PHGDH—breast cancer	5.33e-06	9.69e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—FASN—breast cancer	5.33e-06	9.68e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC2A2—breast cancer	5.32e-06	9.67e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MTHFR—breast cancer	5.31e-06	9.65e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—BCHE—breast cancer	5.3e-06	9.64e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	5.26e-06	9.57e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC5A5—breast cancer	5.24e-06	9.53e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—BRIP1—breast cancer	5.23e-06	9.51e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HPSE—breast cancer	5.23e-06	9.51e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—LDHB—breast cancer	5.23e-06	9.51e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CPT1A—breast cancer	5.21e-06	9.47e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MTR—breast cancer	5.21e-06	9.47e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ABCG2—breast cancer	5.21e-06	9.47e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HPGDS—breast cancer	5.11e-06	9.29e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HBA1—breast cancer	5.08e-06	9.23e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC2A1—breast cancer	5.06e-06	9.2e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NQO1—breast cancer	5.06e-06	9.2e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTA3—breast cancer	4.96e-06	9.01e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ABCC1—breast cancer	4.96e-06	9.01e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HMMR—breast cancer	4.96e-06	9.01e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTT1—breast cancer	4.96e-06	9.01e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ACHE—breast cancer	4.96e-06	9.01e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.95e-06	9.01e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP3A4—breast cancer	4.93e-06	8.97e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.91e-06	8.93e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CAV1—breast cancer	4.89e-06	8.9e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP1B1—breast cancer	4.85e-06	8.82e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.8e-06	8.73e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HSP90AA1—breast cancer	4.76e-06	8.65e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP17A1—breast cancer	4.69e-06	8.53e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.68e-06	8.5e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ENO1—breast cancer	4.64e-06	8.44e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTGS1—breast cancer	4.64e-06	8.44e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NCOA1—breast cancer	4.63e-06	8.41e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.63e-06	8.41e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.57e-06	8.3e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—STK11—breast cancer	4.56e-06	8.29e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP19A1—breast cancer	4.56e-06	8.29e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP2D6—breast cancer	4.55e-06	8.28e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTA4—breast cancer	4.53e-06	8.24e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CA9—breast cancer	4.53e-06	8.24e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NCOA2—breast cancer	4.47e-06	8.13e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CG—breast cancer	4.46e-06	8.11e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTA2—breast cancer	4.42e-06	8.03e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GPX2—breast cancer	4.42e-06	8.03e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GPX4—breast cancer	4.36e-06	7.93e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SULT1A1—breast cancer	4.36e-06	7.93e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—FASN—breast cancer	4.33e-06	7.88e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—BCHE—breast cancer	4.32e-06	7.85e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.28e-06	7.78e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC5A5—breast cancer	4.26e-06	7.75e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—IDH1—breast cancer	4.26e-06	7.75e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTA1—breast cancer	4.26e-06	7.75e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—COMT—breast cancer	4.24e-06	7.71e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTP1—breast cancer	4.22e-06	7.67e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NAT2—breast cancer	4.21e-06	7.66e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HMOX1—breast cancer	4.16e-06	7.57e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ITPR1—breast cancer	4.15e-06	7.55e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NQO1—breast cancer	4.12e-06	7.49e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC2A1—breast cancer	4.12e-06	7.49e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.03e-06	7.33e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP3A4—breast cancer	4.02e-06	7.3e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4e-06	7.27e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ABCB1—breast cancer	3.99e-06	7.26e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP1B1—breast cancer	3.95e-06	7.18e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TYMS—breast cancer	3.92e-06	7.13e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CD—breast cancer	3.92e-06	7.13e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NCOR1—breast cancer	3.88e-06	7.05e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTM1—breast cancer	3.88e-06	7.05e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PLA2G4A—breast cancer	3.88e-06	7.05e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.87e-06	7.04e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ALB—breast cancer	3.87e-06	7.03e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NCOA1—breast cancer	3.77e-06	6.85e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GPX1—breast cancer	3.71e-06	6.75e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—STK11—breast cancer	3.71e-06	6.75e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP19A1—breast cancer	3.71e-06	6.75e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NOS3—breast cancer	3.7e-06	6.73e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MED12—breast cancer	3.7e-06	6.72e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—DPYD—breast cancer	3.7e-06	6.72e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP1A1—breast cancer	3.68e-06	6.68e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ERCC2—breast cancer	3.65e-06	6.63e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALDOA—breast cancer	3.64e-06	6.62e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NCOA3—breast cancer	3.53e-06	6.42e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC2A2—breast cancer	3.51e-06	6.38e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.48e-06	6.34e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—COMT—breast cancer	3.45e-06	6.27e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ABCG2—breast cancer	3.44e-06	6.25e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CPT1A—breast cancer	3.44e-06	6.25e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MTR—breast cancer	3.44e-06	6.25e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTP1—breast cancer	3.43e-06	6.25e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MTHFR—breast cancer	3.43e-06	6.23e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CB—breast cancer	3.42e-06	6.21e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HMOX1—breast cancer	3.39e-06	6.16e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTGS2—breast cancer	3.38e-06	6.15e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ITPR1—breast cancer	3.38e-06	6.15e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HPGDS—breast cancer	3.37e-06	6.13e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HBA1—breast cancer	3.35e-06	6.09e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ACHE—breast cancer	3.27e-06	5.94e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTT1—breast cancer	3.27e-06	5.94e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ABCB1—breast cancer	3.25e-06	5.91e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TYMS—breast cancer	3.19e-06	5.81e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CAV1—breast cancer	3.16e-06	5.75e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NCOR1—breast cancer	3.16e-06	5.74e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.16e-06	5.74e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTM1—breast cancer	3.16e-06	5.74e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP17A1—breast cancer	3.09e-06	5.62e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ENO1—breast cancer	3.06e-06	5.57e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTGS1—breast cancer	3.06e-06	5.57e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GPX1—breast cancer	3.02e-06	5.5e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.02e-06	5.49e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP2D6—breast cancer	3e-06	5.46e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP1A1—breast cancer	2.99e-06	5.44e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ERCC2—breast cancer	2.97e-06	5.4e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTEN—breast cancer	2.95e-06	5.37e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NCOA2—breast cancer	2.95e-06	5.36e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CG—breast cancer	2.88e-06	5.24e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—FASN—breast cancer	2.86e-06	5.2e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—BCHE—breast cancer	2.85e-06	5.18e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC5A5—breast cancer	2.81e-06	5.11e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MTHFR—breast cancer	2.79e-06	5.07e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NQO1—breast cancer	2.72e-06	4.94e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC2A1—breast cancer	2.72e-06	4.94e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP1B1—breast cancer	2.6e-06	4.73e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CAV1—breast cancer	2.57e-06	4.68e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.55e-06	4.64e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CD—breast cancer	2.53e-06	4.6e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ALB—breast cancer	2.5e-06	4.54e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NCOA1—breast cancer	2.48e-06	4.52e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.46e-06	4.47e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—STK11—breast cancer	2.45e-06	4.45e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP19A1—breast cancer	2.45e-06	4.45e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NOS3—breast cancer	2.39e-06	4.35e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CG—breast cancer	2.34e-06	4.26e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—COMT—breast cancer	2.28e-06	4.14e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTP1—breast cancer	2.27e-06	4.12e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HMOX1—breast cancer	2.23e-06	4.06e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ITPR1—breast cancer	2.23e-06	4.05e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CB—breast cancer	2.21e-06	4.01e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTGS2—breast cancer	2.19e-06	3.98e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ABCB1—breast cancer	2.14e-06	3.9e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TYMS—breast cancer	2.11e-06	3.83e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CA—breast cancer	2.08e-06	3.79e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTM1—breast cancer	2.08e-06	3.78e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.08e-06	3.78e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NCOR1—breast cancer	2.08e-06	3.78e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CD—breast cancer	2.06e-06	3.75e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ALB—breast cancer	2.03e-06	3.7e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GPX1—breast cancer	1.99e-06	3.62e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP1A1—breast cancer	1.97e-06	3.59e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ERCC2—breast cancer	1.96e-06	3.56e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NOS3—breast cancer	1.95e-06	3.54e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTEN—breast cancer	1.91e-06	3.47e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MTHFR—breast cancer	1.84e-06	3.35e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CB—breast cancer	1.8e-06	3.27e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTGS2—breast cancer	1.78e-06	3.24e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—AKT1—breast cancer	1.7e-06	3.09e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CAV1—breast cancer	1.7e-06	3.09e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTEN—breast cancer	1.55e-06	2.82e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CG—breast cancer	1.55e-06	2.81e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CD—breast cancer	1.36e-06	2.47e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CA—breast cancer	1.35e-06	2.45e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ALB—breast cancer	1.34e-06	2.44e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NOS3—breast cancer	1.28e-06	2.33e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CB—breast cancer	1.18e-06	2.15e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTGS2—breast cancer	1.17e-06	2.13e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AKT1—breast cancer	1.1e-06	2e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CA—breast cancer	1.09e-06	1.99e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTEN—breast cancer	1.02e-06	1.86e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AKT1—breast cancer	8.94e-07	1.63e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CA—breast cancer	7.22e-07	1.31e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AKT1—breast cancer	5.9e-07	1.07e-05	CbGpPWpGaD
